Loading clinical trials...
Loading clinical trials...
Dolutegravir (DTG) is recommended for both treatment-naïve and treatment-experienced, HIV infected adults and paediatric subjects aged 12 years and older and weighing at least 40 kg. One case of suspe...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ViiV Healthcare
Collaborators
NCT00044577 · Infection, Human Immunodeficiency Virus I, HIV Infection
NCT00094523 · Infection, Human Immunodeficiency Virus I
NCT01263015 · Infection, Human Immunodeficiency Virus I
NCT00242840 · Infection, Human Immunodeficiency Virus I, HIV Infection
NCT00104429 · Infection, Human Immunodeficiency Virus I, HIV Infection
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions